Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

Adjuvant chemoimmunotherapy with LMF plus BCG in node-negative and node-positive breast cancer - intermediate report at 4 years.

Senn, H J; Amgwerd, R; Jungi, W F; Hochuli, R; Ammann, J; Engelhart, G; Heinz, C; Wick, A; Enderlin, F; Creux, G; Simon, B; Lanz, R; Bigler, R; Seiler, S.

Recent Results Cancer Res ; 80: 177-84, 1982.

Artículo en Inglés | MEDLINE | ID: mdl-7036281

2.

Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer: 8 year results.

Senn, H J; Jungi, W F; Amgwerd, R; Hochuli, E; Ammann, J; Engelhart, G; Heinz, C; Wick, A; Enderlin, F; Creux, G.

Recent Results Cancer Res ; 96: 90-101, 1984.

Artículo en Inglés | MEDLINE | ID: mdl-6528092

3.

Swiss adjuvant trial (OSAKO 06/74) with chlorambucil, methotrexate, and 5-fluorouracil plus BCG in node-negative breast cancer patients: nine-year results.

Senn, H J; Jungi, W F; Amgwerd, R; Hochuli, E; Ammann, J; Engelhart, G; Heinz, C; Wick, A; Enderlin, F; Creux, G.

NCI Monogr ; (1): 129-34, 1986.

Artículo en Inglés | MEDLINE | ID: mdl-3534585

4.

Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients. Intermediate report of a randomized trial in 242 patients.

Senn, H J; Jungi, W F; Amgwerd, R; Sprenger, F; Hochueli, R; Engelhart, G; Heinz, C; Wick, A; Enderlin, F; Creux, G; Simeon, B; Lanz, R; Bigler, R.

Antibiot Chemother (1971) ; 24: 213-28, 1978.

Artículo en Inglés | MEDLINE | ID: mdl-350137

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Adjuvant chemoimmunotherapy with LMF plus BCG in node-negative and node-positive breast cancer - intermediate report at 4 years.

Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer: 8 year results.

Swiss adjuvant trial (OSAKO 06/74) with chlorambucil, methotrexate, and 5-fluorouracil plus BCG in node-negative breast cancer patients: nine-year results.

Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients. Intermediate report of a randomized trial in 242 patients.